ENTITY

Relypsa Inc (RLYP US)

Health Care • United States

Relypsa, Inc. operates as a pharmaceuticals company. The Company develops and markets non-absorbed polymeric drugs to treat renal, cardiovascular, and metabolic diseases.

Refresh

Focused

No publications yet

Add Relypsa Inc to your Watchlist to get alerts on new publications

Add to Watchlist

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00